Hemogenyx Pharmaceuticals reports 1H results

Sep. 29, 2022 6:17 AM ETHemogenyx Pharmaceuticals Plc (HOPHF)By: Deepa Sarvaiya, SA News Editor
  • Hemogenyx Pharmaceuticals press release (OTCPK:HOPHF): 1H Loss of £1.30M.
  • Cash and cash equivalents totalling £5,799,495 as at 30 June 2022.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.